MCKESSON CORPORATION - MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025.
Key Details
Description
MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025.
Context & Analysis
On Dec 3, 2025, Department of Justice obligated $10,000,000 to MCKESSON CORPORATION for mckesson: non-controlled medication dos: october 1, 2025 thru december 31, 2025.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in IRVING, TX. This award is one of several similar procurements from Department of Justice under NAICS 325412 — related awards are listed below.
Market context
- Recompete outlook
- Ended Dec 31, 2025 (10 months ago). Recompete signal as of Oct 13, 2026: 48/100, combining time to the end date, the incumbent's history with this agency, whether the award was competed, and its size.
- Competition
- Competed. 97% of 1000 awards in this market (Department of Justice awards in NAICS 325412 over the last 3 years) were competed; median 1 offers.
- Award size
- At $10.0M, this award is larger than 19 in 20 of the 1111 priced Department of Justice awards in NAICS 325412 over the last 3 years (median $17K).
- Incumbent at this agency
- MCKESSON CORPORATION has 898 other awards from Department of Justice, totalling $123.6M, 2025–2026.
- Largest vendors in this market
By obligations, Department of Justice awards in NAICS 325412 over the last 3 years.
- TAKEDA PHARMACEUTICALS AMERICA INC — 4 awards, $748K
- PRIORITY HEALTHCARE DISTRIBUTION INC — 10 awards, $514K
- PETNET SOLUTIONS, INC. — 2 awards, $512K
- COVERMYMEDS PHARMACY LLC — 1 award, $272K
- ACTELION PHARMACEUTICALS US, INC. — 7 awards, $187K
Computed from USAspending award data on Oct 13, 2026.
Contractor Information
Similar Awards
MCKESSON NON-CONTROLLED DOS: NOV 1- CR MARCH 14, 2024
MCKESSON CORPORATION
$29.2M
PPV PHARMACEUTICAL ITEMS - FISCAL YEAR 25 PROCUREMENT OF PHARMACEUTICALS ON THE PPV
MCKESSON CORPORATION
$5.3M
MCKESSON STANDARD MEDICATION FY 2025
MCKESSON CORPORATION
$4.4M
SCHEDULE/CONTRACT MEDICATIONS FY 25
MCKESSON CORPORATION
$2.5M
FY25 MCKESSON MAT MEDICATIONS
MCKESSON CORPORATION
$1.8M
Stay Updated
Get notified about new opportunities matching your interests.